Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support

Sponsor
ProMedica Health System (Other)
Overall Status
Completed
CT.gov ID
NCT02048280
Collaborator
(none)
15
1
1
28
0.5

Study Details

Study Description

Brief Summary

Neurally adjusted ventilatory assist (NAVA) is a mode of mechanical ventilation that uses the diaphragm's normal electrical activity to deliver a mechanically supported breath. The amount of support provided is determined in part by the NAVA level, where a higher NAVA level will provide higher level of support and unload more of the work of the diaphragm. The purpose of this study is to compare the optimal NAVA level in neonates while on mechanical ventilation while intubated and after being extubated.

Condition or Disease Intervention/Treatment Phase
  • Procedure: NAVA level
  • Other: NAVA level
N/A

Detailed Description

Baseline measurements will be taken. The NAVA titration study will then be done. The NAVA level will be set at a starting value of 0.1 cm H2O/mcV and systematically increased by 0.5 cm H2O/mcV every three minutes to a maximum of 3 cmH2O/mcV. Once the NAVA titration study has been completed, the patient will be extubated. There will be a stabilization period following extubation (15-30 minutes), and then the NAVA titration study will be repeated.

Study Design

Study Type:
Interventional
Actual Enrollment :
15 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support
Study Start Date :
Dec 1, 2012
Actual Primary Completion Date :
Jun 1, 2014
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
Experimental: Intubated

NAVA level from 0.1 to 3

Procedure: NAVA level
Peak inspiratory pressure will be measured at each NAVA level

Other: NAVA level
Increase NAVA level every 3 minutes

Outcome Measures

Primary Outcome Measures

  1. Changes in breakpoint in intubated and extubated patients [20 minute study pre and post extubation]

    NAVA titration study will be done pre and post extubation to determine and then compare the breakpoint.

Eligibility Criteria

Criteria

Ages Eligible for Study:
23 Weeks to 40 Weeks
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Neonates on NAVA ventilation
Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 Promedica Toledo CHildren's Hospital NICU Toledo Ohio United States 43606

Sponsors and Collaborators

  • ProMedica Health System

Investigators

  • Principal Investigator: Howard Stein, MD, Promedica Toledo Childrne's Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
ProMedica Health System
ClinicalTrials.gov Identifier:
NCT02048280
Other Study ID Numbers:
  • TCH02
First Posted:
Jan 29, 2014
Last Update Posted:
Jul 30, 2015
Last Verified:
Jul 1, 2015

Study Results

No Results Posted as of Jul 30, 2015